🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Texas › Houston

Diffuse Intrinsic Pontine Glioma clinical trials in Houston, TX

10 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RecruitingPhase 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · All sexes · Updated Sep 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

RecruitingPhase 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
36 Months · All sexes · Updated Sep 9, 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Texas Children's Hospital, Houston
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Texas Children's Hospital, Houston
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Texas Children's Hospital, Houston
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

RecruitingPhase 1
  • Texas Children's Hospital, Houston
12 Months – 25 Years · All sexes · Updated Aug 3, 2026 · NCT04099797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Texas Children's Hospital, Houston
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Texas Children's Hospital, Houston
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RecruitingEarly phase 1
  • Texas Children's Hospital, Houston
Up to age 21 · All sexes · Updated Mar 18, 2026 · NCT04655404

Diffuse Intrinsic Pontine Glioma trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.